2OQV image
Deposition Date 2007-02-01
Release Date 2007-04-24
Last Version Date 2024-10-16
Entry Detail
PDB ID:
2OQV
Keywords:
Title:
Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.30
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Dipeptidyl peptidase 4 (Dipeptidyl peptidase IV) (DPP IV)
Gene (Uniprot):DPP4
Chain IDs:A, B
Chain Length:726
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Discovery and Structure-Activity Relationships of Piperidinone- and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors.
J.Med.Chem. 50 1983 1987 (2007)
PMID: 17367123 DOI: 10.1021/jm061436d

Abstact

Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of therapeutic agents for the treatment of type 2 diabetes. They exert their beneficial effects by increasing the levels of active glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, which are two important incretins for glucose homeostasis. Starting from a high-throughput screening hit, we were able to identify a series of piperidinone- and piperidine-constrained phenethylamines as novel DPP4 inhibitors. Optimized compounds are potent, selective, and have good pharmacokinetic profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures